Zusammenfassung
Bei Patienten mit hepatozellulärem Karzinom (HCC) ist die chirurgische Resektion die einzige lebensverlängernde Therapie und damit Methode der Wahl. Aus operationstechnischen Gründen und wegen der oft ausgeprägten Leberzirrhose sind weniger als 30% der Patienten resektabel. Als vielversprechende Alternative zur Resektion wird die Radiofrequenzablation (RFA) zunehmend zur Behandlung nichtresektabler Lebertumoren eingesetzt.
Entscheidende Fortschritte bei der Entwicklung leistungsfähiger Generatoren (bis 250 W) in Kombination mit expandierbaren oder gekühlten Nadelelektroden ermöglichen In-vivo-Ablationsareale bis über 5 cm.
Neuesten Daten zu Folge liegt die primäre technische Erfolgsrate der RFA von HCCs zwischen 85 und 100%. Nach RFA von HCCs (Durchmesser bis 2,8 cm) beträgt die Überlebenswahrscheinlichkeit nach 1, 2, 3, und 5 Jahren 97, 89, 71 und 48%. Komplikationsraten von 0–12% und eine Mortalität von 0–1% belegen den minimal-invasiven Charakter dieser Methode. Die grundlegenden Prinzipien der RFA, Indikationen, Kontraindikationen und Limitationen werden anhand eigener Fälle und der aktuellen Literatur dargestellt.
Abstract
In patients with hepatocellular carcinoma (HCC) surgical resection so far offers potential cure. Due to the frequent association with liver cirrhosis less then 30% of patients with HCC can be resected. In unresectable cases, radiofrequency ablation (RFA) offers an effective treatment alternative. Substantial improvements in the development of powerful generators (up to 250 W) combined with expandable, closed or open-perfused needle electrodes, provide coagulation necroses up to 5 cm in diameter. Most recently primary technical success rates of 85 to 100% were reported. Following RFA of HCC’s (diameter up to 2,8 cm) 1-, 2-, 3 and 5-year survival was reported to be 97, 89, 71 and 48%. Low complication rates of 0–12% and a mortality of 0–1% indicate the minimal-invasive character of RFA.
Basic principles, technique, indications, contraindications and limitations of percutaneous RFA will be discussed together with a presentation of own cases and a review of literature.
Literatur
Rossi S FF, Buscarini L (1993) Percutaneous ultrasound-guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma. J Intervent Radiol 8:97–103
Rossi S, Di Stasi M, Buscarini E, Quaretti P, Garbagnati F, Squassante L, Paties CT, Silverman DE, Buscarini L (1996) Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 167:759–768
Dodd GD 3rd, Soulen MC, Kane RA, Livraghi T, Lees WR, Yamashita Y, Gillams AR, Karahan OI, Rhim H (2000) Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 20:9–27
Nahum Goldberg S, Dupuy DE (2001) Image-guided radiofrequency tumor ablation: challenges and opportunities, part I. J Vasc Interv Radiol 12:1021–1032
Helmberger T, Holzknecht N, Schopf U, Kulinna C, Rau H, Stabler A, Reiser M (2001) [Radiofrequency ablation of liver metastases. Technique and initial results]. Radiologe 41:69–76
Rossi S, Buscarini E, Garbagnati F, Di Stasi M, Quaretti P, Rago M, Zangrandi A, Andreola S, Silverman D, Buscarini L (1998) Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 170:1015–1022
Mahnken AH, Tacke J, Bucker A, Gunther RW (2002) [Percutaneous radiofrequency ablation of liver malignancies: first experience with a 200-W radiofrequency generator]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 174:216–223
Livraghi T, Goldberg SN, Monti F, Bizzini A, Lazzaroni S, Meloni F, Pellicano S, Solbiati L, Gazelle GS (1997) Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 202:205–210
Kettenbach J, Kostler W, Rucklinger E, Gustorff B, Hupfl M, Wolf F, Peer K, Weigner M, Lammer J, Muller W, Goldberg SN (2003) Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. AJR Am J Roentgenol 180:1537–1545
Hansler J, Frieser M, Schaber S, Kutschall C, Bernatik T, Muller W, Becker D, Hahn EG, Strobel D (2003) Radiofrequency ablation of hepatocellular carcinoma with a saline solution perfusion device: a pilot study. J Vasc Interv Radiol 14:575–580
Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88:2452–2463
Denys AL, De Baere T, Kuoch V, Dupas B, Chevallier P, Madoff DC, Schnyder P, Doenz F (2003) Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems. Eur Radiol 13:2346–2352
Pereira PL, Trubenbach J, Schmidt D (2003) [Radiofrequency ablation: basic principles, techniques and challenges]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 175:20–27
Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR (1996) Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 3:636–644
Goldberg SN, Solbiati L, Hahn PF, Cosman E, Conrad JE, Fogle R, Gazelle GS (1998) Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 209:371–379
Brieger J, Pereira PL, Trubenbach J, Schenk M, Krober SM, Schmidt D, Aube C, Claussen CD, Schick F (2003) In vivo efficiency of four commercial monopolar radiofrequency ablation systems: a comparative experimental study in pig liver. Invest Radiol 38:609–616
Solbiati L, Tonolini M, Cova L, Goldberg SN (2001) The role of contrast-enhanced ultrasound in the detection of focal liver leasions. Eur Radiol 11 [suppl 3]:E15–26
Lewin JS, Connell CF, Duerk JL, Chung YC, Clampitt ME, Spisak J, Gazelle GS, Haaga JR (1998) Interactive MRI-guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging 8:40–47
Choi H, Loyer EM, DuBrow RA, Kaur H, David CL, Huang S, Curley S, Charnsangavej C (2001) Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 21 Spec No:S41–54
Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS (1999) Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 210:655–661
Ikeda M, Okada S, Ueno H, Okusaka T, Kuriyama H (2001) Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study. Jpn J Clin Oncol 31:322–326
Poon RT, Fan ST, Tsang FH, Wong J (2002) Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 235:466–486
Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, Gazelle GS (2000) Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 214:761–768
Llovet JM, Vilana R, Bru C, Bianchi L, Salmeron JM, Boix L, Ganau S, Sala M, Pages M, Ayuso C, Sole M, Rodes J, Bruix J (2001) Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 33:1124–1129
Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P (2000) Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232:381–391
Elias D, De Baere T, Smayra T, Ouellet JF, Roche A, Lasser P (2002) Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg 89:752–756
Lencioni R, Crocetti L, Ciau D, Franchini C, Lera I, Della Pina C et al. (2004) Long-term results of percutaneous radiofrequency ablation in the treatment of a small hepatocellular carcinoma in cirrhosis. European Radiology 14 [Suppl 2]:137
Choti MA (2002) Surgical management of hepatocellular carcinoma: resection and ablation. J Vasc Interv Radiol 13:S197–203
Choi D, Lim HK, Kim MJ, Lee SH, Kim SH, Lee WJ, Lim JH, Joh JW, Kim YI (2004) Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 230:135–141
Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–451
Rhim H, Goldberg SN, Dodd GD 3rd, Solbiati L, Lim HK, Tondini M, Cho OK et al. (2001) Essential techniques for successful radio-frequency thermal ablation of malignant liver tumors. Radiographics 21 Spec No:17–35; discussion 36–39
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kettenbach, J., Blum, M., Kilanowicz, E. et al. Perkutane Radiofrequenzablation von Leberzellkarzinomen: eine aktuelle Übersicht. Radiologe 44, 330–338 (2004). https://doi.org/10.1007/s00117-004-1031-y
Issue Date:
DOI: https://doi.org/10.1007/s00117-004-1031-y